Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
TriSalus Life Sciences Analyst Ratings and Price Targets | NASDAQ:TLSI | Benzinga
TriSalus Life Sciences Inc has a consensus price target of $11.5 based on the ratings of 7 analysts. The high is $16 issued by JonesTrading on May 10, 2024. The low is $10 issued by Lake Street on February 13, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Lake Street, and Roth MKM on March 28, 2025, February 13, 2025, and January 24, 2025, respectively. With an average price target of $10.67 between Canaccord Genuity, Lake Street, and Roth MKM, there's an implied 117.69% upside for TriSalus Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Lake Street
Roth MKM
Cantor Fitzgerald
Northland Capital Markets
1calculated from analyst ratings
Analyst Ratings for TriSalus Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/28/2025 | Buy Now | 124.49% | Canaccord Genuity | William Plovanic57% | $11 → $11 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 104.08% | Lake Street | — | → $10 | Initiates | → Buy | Get Alert |
| 01/24/2025 | Buy Now | 124.49% | Roth MKM | Jason Wittes52% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | Buy Now | 104.08% | Cantor Fitzgerald | Prakhar Agrawal44% | → $10 | Initiates | → Overweight | Get Alert |
| 11/15/2024 | Buy Now | 124.49% | Canaccord Genuity | William Plovanic57% | $12 → $11 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | 124.49% | Roth MKM | Jason Wittes52% | → $11 | Initiates | → Buy | Get Alert |
| 10/25/2024 | Buy Now | 155.1% | Northland Capital Markets | Carl Byrnes57% | → $12.5 | Initiates | → Outperform | Get Alert |
| 09/16/2024 | Buy Now | 104.08% | Oppenheimer | Suraj Kalia58% | → $10 | Initiates | → Outperform | Get Alert |
| 06/27/2024 | Buy Now | 144.9% | Canaccord Genuity | William Plovanic57% | $12 → $12 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 144.9% | Canaccord Genuity | William Plovanic57% | → $12 | Initiates | → Buy | Get Alert |
| 05/10/2024 | Buy Now | 226.53% | JonesTrading | Justin Walsh41% | → $16 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for TriSalus Life Sciences (TLSI) stock?
The latest price target for TriSalus Life Sciences (NASDAQ:TLSI) was reported by Canaccord Genuity on March 28, 2025. The analyst firm set a price target for $11.00 expecting TLSI to rise to within 12 months (a possible 124.49% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TriSalus Life Sciences (TLSI)?
The latest analyst rating for TriSalus Life Sciences (NASDAQ:TLSI) was provided by Canaccord Genuity, and TriSalus Life Sciences maintained their buy rating.
When was the last upgrade for TriSalus Life Sciences (TLSI)?
There is no last upgrade for TriSalus Life Sciences
When was the last downgrade for TriSalus Life Sciences (TLSI)?
There is no last downgrade for TriSalus Life Sciences.
When is the next analyst rating going to be posted or updated for TriSalus Life Sciences (TLSI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TriSalus Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TriSalus Life Sciences was filed on March 28, 2025 so you should expect the next rating to be made available sometime around March 28, 2026.
Is the Analyst Rating TriSalus Life Sciences (TLSI) correct?
While ratings are subjective and will change, the latest TriSalus Life Sciences (TLSI) rating was a maintained with a price target of $11.00 to $11.00. The current price TriSalus Life Sciences (TLSI) is trading at is $4.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
